Gastric metastasis from hormone receptor–positive breast cancer ten years after radical mastectomy: a case report and literature review - Report - MDSpire
Advertisement
Gastric metastasis from hormone receptor–positive breast cancer ten years after radical mastectomy: a case report and literature review
Clinical Report: Gastric Metastasis of Hormone Receptor-Positive Breast Cancer
Overview
This report details a case of gastric metastasis from hormone receptor-positive breast cancer occurring a decade post-radical mastectomy. The diagnosis was challenging due to nonspecific gastrointestinal symptoms, highlighting the need for careful evaluation in long-term breast cancer survivors.
Background
Breast cancer is the most prevalent malignancy among women, with gastrointestinal metastases being rare. Gastric involvement, particularly from invasive ductal carcinoma, is uncommon and can mimic primary gastric cancer, complicating diagnosis. Understanding this phenomenon is crucial for timely and accurate treatment in breast cancer survivors.
Data Highlights
No numerical data or trial data was provided in the source material.
Key Findings
A 59-year-old woman developed gastric metastasis from breast cancer 10 years post-mastectomy.
Symptoms included epigastric discomfort and dysphagia, which were initially misattributed to benign gastrointestinal issues.
Histopathological examination confirmed hormone receptor-positive, HER2-negative metastatic breast carcinoma.
Endoscopic biopsy and immunohistochemistry were critical for accurate diagnosis.
Treatment with a CDK4/6 inhibitor and aromatase inhibitor led to rapid symptom relief and disease stabilization.
Clinical Implications
Healthcare professionals should maintain a high index of suspicion for late gastrointestinal metastasis in breast cancer survivors presenting with nonspecific symptoms. Multidisciplinary evaluation and advanced diagnostic techniques are essential for accurate diagnosis and effective management.
Conclusion
This case underscores the rarity of gastric metastasis from breast cancer and the importance of vigilant follow-up in long-term survivors. Early recognition and appropriate treatment can significantly improve patient outcomes.
